News
British animal genetics company Genus on Wednesday said the U.S. Food and Drug Administration (FDA) approved its PRP gene ...
Regulus Therapeutics said on Wednesday Swiss drugmaker Novartis has agreed to buy the drug developer for up to $1.7 billion ...
Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with ...
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa ...
22hOpinion
MedPage Today on MSNA Conversation With FDA Commissioner Marty MakaryAmong other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...
AI is a transformational force in healthcare, but without cybersecurity as its foundation, it becomes a high-stakes gamble.
A shocking report on mifepristone has finally shown a light on how the FDA is harming, and even killing, thousands of women.
Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...
v) Prepare and file a NDA for marketing approval of XORLO™.
The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...
For executives racing to lead in healthcare AI, I see the European Union, the United States and China as the leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results